Role of oxidative stress in preeclampsia and intrauterine growth restriction I Mert, A Sargın Oruc, S Yuksel, ES Cakar, U Buyukkagnıcı, A Karaer, ... Journal of Obstetrics and Gynaecology Research 38 (4), 658-664, 2012 | 192 | 2012 |
Bioenergetic adaptations in chemoresistant ovarian cancer cells S Dar, J Chhina, I Mert, D Chitale, T Buekers, H Kaur, S Giri, A Munkarah, ... Scientific reports 7 (1), 8760, 2017 | 149 | 2017 |
Folic acid tagged nanoceria as a novel therapeutic agent in ovarian cancer M Hijaz, S Das, I Mert, A Gupta, Z Al-Wahab, C Tebbe, S Dar, J Chhina, ... BMC cancer 16, 1-14, 2016 | 138 | 2016 |
Visfatin concentration is decreased in women with gestational diabetes mellitus in the third trimester M Akturk, AE Altinova, I Mert, U Buyukkagnici, A Sargin, M Arslan, ... Journal of endocrinological investigation 31, 610-613, 2008 | 67 | 2008 |
Vulvar/vaginal melanoma: an updated surveillance epidemiology and end results database review, comparison with cutaneous melanoma and significance of racial disparities I Mert, A Semaan, I Winer, RT Morris, R Ali-Fehmi International Journal of Gynecologic Cancer 23 (6), 2013 | 66 | 2013 |
Evidence of fetal central nervous system injury in isolated congenital heart defects: microcephaly at birth D Barbu, I Mert, M Kruger, RO Bahado-Singh American journal of obstetrics and gynecology 201 (1), 43. e1-43. e7, 2009 | 52 | 2009 |
Metformin prevents aggressive ovarian cancer growth driven by high-energy diet: similarity with calorie restriction Z Al-Wahab, I Mert, C Tebbe, J Chhina, M Hijaz, RT Morris, R Ali-Fehmi, ... Oncotarget 6 (13), 10908, 2015 | 51 | 2015 |
Clear cell carcinoma arising in the abdominal wall: two case reports and literature review I Mert, A Semaan, S Kim, R Ali-Fehmi, RT Morris American journal of obstetrics and gynecology 207 (2), e7-e9, 2012 | 47 | 2012 |
Significance of lymphovascular space invasion in uterine serous carcinoma: what matters more; extent or presence? I Winer, QF Ahmed, I Mert, S Bandyopadhyay, M Cote, AR Munkarah, ... International Journal of Gynecological Pathology 34 (1), 47-56, 2015 | 44 | 2015 |
Management of squamous cell vulvar cancer: a review G Deppe, I Mert, IS Winer Journal of Obstetrics and Gynaecology Research 40 (5), 1217-1225, 2014 | 42 | 2014 |
Asymmetric dimethylarginine concentrations are elevated in women with gestational diabetes M Akturk, A Altinova, I Mert, A Dincel, A Sargin, U Buyukkagnici, M Arslan, ... Endocrine 38, 134-141, 2010 | 41 | 2010 |
Case for a role of the microbiome in gynecologic cancers: Clinician's perspective I Mert, M Walther‐Antonio, A Mariani Journal of Obstetrics and Gynaecology Research 44 (9), 1693-1704, 2018 | 39 | 2018 |
Clinical and pathologic characteristics of serous carcinoma confined to the endometrium: a multi-institutional study A Semaan, I Mert, AR Munkarah, S Bandyopadhyay, HS Mahdi, IS Winer, ... International Journal of Gynecological Pathology 32 (2), 181-187, 2013 | 36 | 2013 |
Cardiovascular risk factors in polycystic ovary syndrome A Karaer, S Cavkaytar, I Mert, U Buyukkagnici, S Batioglu Journal of Obstetrics and Gynaecology 30 (4), 387-392, 2010 | 36 | 2010 |
Serological investigation of the role of selected sexually transmitted infections in the aetiology of ectopic pregnancy A Karaer, I Mert, S Cavkaytar, S Batioglu The European Journal of Contraception & Reproductive Health Care 18 (1), 68-74, 2013 | 33 | 2013 |
Synergistic effect of MEK inhibitor and metformin combination in low grade serous ovarian cancer I Mert, J Chhina, G Allo, J Dai, S Seward, MS Carey, M Llaurado, S Giri, ... Gynecologic oncology 146 (2), 319-326, 2017 | 31 | 2017 |
Ghrelin and motilin levels in hyperemesis gravidarum AS Oruç, I Mert, M Akturk, E Aslan, B Polat, U Buyukkagnıcı, N Danışman Archives of gynecology and obstetrics 287, 1087-1092, 2013 | 31 | 2013 |
Clinical significance of enlarged cardiophrenic lymph nodes in advanced ovarian cancer: Implications for survival I Mert, A Kumar, SP Sheedy, AL Weaver, ME McGree, B Kim, WA Cliby Gynecologic oncology 148 (1), 68-73, 2018 | 29 | 2018 |
Preclinical evaluation of olaparib and metformin combination in BRCA1 wildtype ovarian cancer M Hijaz, J Chhina, I Mert, M Taylor, S Dar, Z Al-Wahab, R Ali-Fehmi, ... Gynecologic oncology 142 (2), 323-331, 2016 | 29 | 2016 |
Chemotherapy of vulvar cancer: a review. G Deppe, I Mert, J Belotte, IS Winer Wiener Klinische Wochenschrift 125, 2013 | 23 | 2013 |